SZSE Ticker: 000623

Jilin Aodong Pharmaceutical Group Co., Ltd.

吉林敖东药业集团股份有限公司

吉林敖东

JLAD

Listing Date: 1996-10-28

Board: Main Board - A Shares

Industry Classification: Manufacturing

29 shares were increased by important shareholders, and Hengli Petrochemical gained the largest amount of increased holdings

Post date May 16, 2022 — 11:34 Post Lock

During the month, 23 important shareholders of listed companies announced to increase their holdings of their own shares.

Post date May 13, 2022 — 23:18 Post Lock

In 2021, 70% of listed companies’ securities investment will be profitable: 233 companies earn more than 100 million yuan, but 196 companies withdraw – yqqlm

Post date May 13, 2022 — 21:44 Post Lock

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:59 Post Lock

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:58 Post Lock

Jilin Aodong's Latest Announcement: The Holding Subsidiary Obtains the Listing Certificate of Traditional Chinese Medicine Formula Granules_Stock News_Market Gold Online

Post date May 5, 2022 — 21:16 Post Lock

Jilin Aodong Subsidiary Sales General Manager Sentenced to 1.91 Years in Prison for Embezzling 1.91 Million

Post date May 3, 2022 — 14:27 Post Lock

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.63% China Universal

Post date April 30, 2022 — 08:40 Post Lock

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.63% China Universal

Post date April 30, 2022 — 08:38 Post Lock

Jilin Aodong plans to spend 150 million yuan to 300 million yuan to buy back the company's shares

Post date April 29, 2022 — 19:26 Post Lock

The domestic liver drug market is expected to reach 100 billion, and the performance of 15 concept stocks is expected to continue to grow rapidly Finance and Economics

Post date April 27, 2022 — 02:37 Post Lock

Many countries have unexplained hepatitis, and the board secretaries of many pharmaceutical companies have responded to hepatitis treatment-related products – yqqlm

Post date April 26, 2022 — 19:51 Post Lock

Zheshang CSI 500 Index Enhanced A Net Worth Down 5.95%

Post date April 26, 2022 — 06:55 Post Lock

[Graphic Quarterly Report] China Universal CSI Traditional Chinese Medicine Index (LOF) A Fund 2022 First Quarterly Report Review_Oriental Fortune Network

Post date April 24, 2022 — 12:05 Post Lock

Jilin Aodong: The company has successively invested in a number of listed pharmaceutical and biological companies with distinctive characteristics and outstanding advantages and strong competitiveness

Post date April 20, 2022 — 21:20 Post Lock

Jilin Aodong: Net profit in 2021 is about 1.781 billion yuan, an increase of 4.19% year-on-year – yqqlm

Post date April 16, 2022 — 22:25 Post Lock

Jilin Aodong: Net profit in 2021 is about 1.781 billion yuan, an increase of 4.19% year-on-year _ Oriental Fortune Net

Post date April 16, 2022 — 20:25 Post Lock

Jilin Aodong: Net profit in 2021 is about 1.781 billion yuan, an increase of 4.19% year-on-year – yqqlm

Post date April 16, 2022 — 20:25 Post Lock

Jilin Aodong: Net profit in 2021 is about 1.781 billion yuan, an increase of 4.19% year-on-year

Post date April 16, 2022 — 20:21 Post Lock

Jilin Aodong announced the 2021 annual equity distribution plan to distribute 3 yuan per 10

Post date April 15, 2022 — 22:01 Post Lock

Want to see more data? Registered subscribers can see all the data.